Benchmark Group PLC
10 July 2003
10 July 2003
Benchmark Concludes £87.8 million of Investment Sales
Benchmark Group PLC ('Benchmark'), the specialist central London investment and
development company, has recently concluded three property investment sales in
central London totalling £87.8 million.
The freehold interest in Landmark House, Hammersmith Bridge Road, W6, owned in a
50/50 joint venture between Benchmark and JER Partners ('BJER'), has been sold
to a private overseas investor for £32 million. The property is an office
building of 8,340 sq m (90,000 sq ft) and is let in its entirety to Diageo PLC
for a term expiring 24 March 2012 at a passing rent of £2.6 million per annum.
The freehold interest in Buchanan House, 3 St James's Square, SW1, owned by the
WEL Property Limited Partnership which is majority owned by the West End of
London Property Unit Trust ('WELPUT') in which Benchmark has an effective
current interest of 55.3% has been sold to a private property company for £36
million. The property is an office building of 4,930 sq m (53,000 sq ft) and is
let in its entirety to a wholly owned subsidiary of Diageo Plc for a term
expiring on 23 June 2014 at a passing rent of £2.5 million per annum.
The long leasehold interest, with 166 years unexpired from the Worshipful
Company of Goldsmiths and a ground rent payable to them of £131,447 per annum,
in 158-164 Bishopsgate, EC2 owned 100% by Benchmark Group PLC has been sold to
Warburg-Henderson KAG, a joint venture between Henderson Global Investors and
M.M. Warburg & Co, Hamburg for £19.8 million. The property is a mixed retail
and office building of 3,815 sq m (41,000 sq ft) let on various leases to
tenants including Tesco plc and Balls Brothers at a total passing rent of £1.3
million per annum.
These sales when combined were achieved at the book value of the properties as
at 31 December 2002.
Following these sales and based on the 31 December 2002 balance sheet figures
Benchmark's pro-forma gearing would be reduced to 75.1% (81.5% at 31 December
2002) and if Benchmark's share of the non-recourse joint venture borrowings was
included, the pro-forma gearing would be 141.3% (159.4% at 31 December 2002).
Nigel Kempner, Chief Executive of Benchmark, said: 'The City sale continues our
policy of reducing exposure to the City market. The sales together show that
there is still strong investor interest for central London investments and help
us to reduce the level of our borrowings on and off balance sheet.'
For further information:
Benchmark Group PLC Tavistock Communications
Nigel Kempner Jeremy Carey/Molly Dover
Tel: 020 7659 0500 Tel: 020 7600 2288
mdover@tavistock.co.uk
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.